Veradermics, Incorporated

MANENYSE • USD
124.69 USD
↘ 3.36 (2.62%)🟢PRE MARKET (AS OF 05:59 AM EST)
🟢Market: OPEN

MANE is currently priced at $124.69. The technical outlook is "Sell" based on moving average alignment, RSI, and MACD signals. Notable factors include negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics place MANE at a fair price relative to peers.

Technical & fundamental data as of Nov 16, 2026.

Open?$128.05
High?$128.05
Low?$124.69
Prev. Close?$128.05
Volume?168
Avg. Volume?831.6K
VWAP?$126.09
Rel. Volume?0.00x
Bid / Ask
Bid?$114.00 × 100
Ask?$131.00 × 100
Spread?$17.00
Midpoint?$122.50
Valuation & Ratios
Market Cap?5.4B
Shares Out?N/A
Float?24.4M
Float %?58.3%
P/E Ratio?N/A
P/B Ratio?6.78
EPS?-$1.77
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.
Employees
21
Market Cap
5.4B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2026-02-04
Address
470 JAMES STREET
NEW HAVEN, CT 06513
Phone: 228.372.3376
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestHigh
Short % of Float?13.90%High
Short Interest?3.4M
Days to Cover?5.1
Free Float24.4M
Avg Daily Volume670.3K
Settlement Date2026-10-30
Financial Health
Current Ratio?77.68Strong
Quick Ratio?77.68Strong
Cash Ratio?12.74Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
27
6.78FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-59.8CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
9
-9.4%WEAK▾
ROA?
S&P
3
-9.2%WEAK▾
Cash Flow & Enterprise
FCF?$-77984000
Enterprise Value?$5.3B
Fundamentals ratios updated end of day